D. UZLU Et Al. , "The evaluation of the efficacy of adalimumab in refractory non-infectious uveitis with ultra-widefield fundus fluorescein angiography," INTERNATIONAL OPHTHALMOLOGY , vol.42, no.7, pp.2107-2116, 2022
UZLU, D. Et Al. 2022. The evaluation of the efficacy of adalimumab in refractory non-infectious uveitis with ultra-widefield fundus fluorescein angiography. INTERNATIONAL OPHTHALMOLOGY , vol.42, no.7 , 2107-2116.
UZLU, D., Kose, B., AKYOL, N., ERDÖL, H., & GÜNAY, M., (2022). The evaluation of the efficacy of adalimumab in refractory non-infectious uveitis with ultra-widefield fundus fluorescein angiography. INTERNATIONAL OPHTHALMOLOGY , vol.42, no.7, 2107-2116.
UZLU, DİLEK Et Al. "The evaluation of the efficacy of adalimumab in refractory non-infectious uveitis with ultra-widefield fundus fluorescein angiography," INTERNATIONAL OPHTHALMOLOGY , vol.42, no.7, 2107-2116, 2022
UZLU, DİLEK Et Al. "The evaluation of the efficacy of adalimumab in refractory non-infectious uveitis with ultra-widefield fundus fluorescein angiography." INTERNATIONAL OPHTHALMOLOGY , vol.42, no.7, pp.2107-2116, 2022
UZLU, D. Et Al. (2022) . "The evaluation of the efficacy of adalimumab in refractory non-infectious uveitis with ultra-widefield fundus fluorescein angiography." INTERNATIONAL OPHTHALMOLOGY , vol.42, no.7, pp.2107-2116.
@article{article, author={DİLEK UZLU Et Al. }, title={The evaluation of the efficacy of adalimumab in refractory non-infectious uveitis with ultra-widefield fundus fluorescein angiography}, journal={INTERNATIONAL OPHTHALMOLOGY}, year=2022, pages={2107-2116} }